Alan Watt

Company: NodThera

Job title: Chief Scientific Officer

Seminars:

Translational Approaches for the Development of Novel NLRP3 Inhibitors 9:00 am

Explore ex vivo stimulated blood assays for early clinical evaluation of pharmacodynamics Use of the D305N NLRP3 mechanistic mouse model for assessment of in vivo target cover Discuss In vivo disease models for PK/PD assessmentRead more

day: Day One